Three-target detection
Consolidates the specified antigen targets into a practical rapid-test workflow.
20 tests
Three-target respiratory antigen test
ANGEL Test COVID-19 & Flu A/B Rapid Antigen Test
Made in Japan. One rapid test for qualitative differentiation of COVID-19, influenza A, and influenza B antigens.
COVID-19Flu AFlu B
For Research Use Only. Not for use in diagnostic procedures.Overview
3 targets. One streamlined test.
TK006 uses a latex-based rapid immunoassay to qualitatively detect and distinguish SARS-CoV-2 and influenza A/B antigens in nasal specimens. It supports research where overlapping respiratory symptoms make a combined workflow useful.
Key features
Designed for speed, clarity, and practical use.
Rapid readout
Provides a visual result in approximately 5-15 minutes, according to the supplied instructions.
Built-in control
A dedicated control line helps confirm correct sample flow and test operation.
Flexible pack sizes
Product photography and supplied materials support single-test and 20-test configurations.
Applications
Flexible across qualified research settings.
The kit is intended for qualified organizations including medical institutions, research organizations, clinics, and care facilities. It is not sold for personal consumer use.
Respiratory pathogen researchClinical research workflowsInstitutional screening studiesComparative assay evaluation
Technical specifications
Product details at a glance.
Catalog numberTK006
Country of originJapan
FormatRapid antigen test
TargetsCOVID-19, influenza A, influenza B
SpecimenNasal swab
Time to resultCOVID-19 from 5 minutes; influenza at 15 minutes; invalid after 20 minutes
Storage4-30°C
Shelf life18 months sealed from manufacture
Pack sizes1 test or 20 tests
Intended useResearch Use Only (RUO); not for diagnostic use
Clinical performance data
Measured performance for TK006.
Values below reproduce the supplied clinical performance summary for TK006. See the downloadable data sheet for details and confidence intervals where provided.
| Target | Sensitivity | Specificity | Total agreement |
|---|---|---|---|
| COVID-19 | 96.70% | 100.00% | 98.90% |
| Flu A | 91.70% | 98.80% | 97.50% |
| Flu B | 86.20% | 98.80% | 96.90% |
Downloads
Product documents.
Related products
Build the right product set for your workflow.
Respiratory Diagnostics
COVID-19 ANGEL Rapid Antigen Test
Made in Japan. A compact rapid test for qualitative detection of the SARS-CoV-2 nucleocapsid antigen in nasal specimens.
Learn more
Respiratory Diagnostics
ANGEL Speed 5-in-1 Rapid Antigen Test
Made in Japan. A multiplex rapid test for COVID-19, RSV, respiratory adenovirus, and influenza A/B antigens.
Learn more
Respiratory Diagnostics
Super ANGEL 6-in-1 Rapid Antigen Test
Made in Japan. A multiplex test for hMPV, COVID-19, RSV, respiratory adenovirus, and influenza A/B.
Learn moreStart a conversation
Contact our team Request pricing or product information for TK006.
Our product team can help with pack sizes, availability, documentation, and distribution inquiries.